Aegerion Pharmaceuticals, Inc. – Indentures – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Indentures Filter

from 8-K 5 pages Supplemental Indenture

from S-3 34 pages Aegerion Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities

from S-3 30 pages Aegerion Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities

from 8-K 93 pages Aegerion Pharmaceuticals, Inc. 2.00% Convertible Senior Notes Due 2019 Indenture Dated as of August 15, 2014 the Bank of New York Mellon Trust Company, N.A., as Trustee

from S-8 16 pages Inducement Award Stock Option Plan Section 1. General Purpose of the Plan; Definitions

from S-3 7 pages Form of Subordinated Note

from S-3 7 pages Form of Senior Note

from S-3 43 pages Aegerion Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities

from S-3 39 pages Aegerion Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities

from S-1/A 2 pages Fully Paid and Non-Assessable Shares of the Par Value of $0.001 Each, of the Common Stock of Aegerion Pharmaceuticals, Inc

from S-1 2 pages Fully Paid and Non-Assessable Shares of the Par Value of $0.001 Each, of the Common Stock of Aegerion Pharmaceuticals, Inc

from S-1/A 2 pages Fully Paid and Non-Assessable Shares of the Par Value of $0.001 Each, of the Common Stock of Aegerion Pharmaceuticals, Inc